Skip to Main Content
Past Events STAT in DC: The Policy Prescription
  • Washington, DC
  • Featured

STAT in DC: The Policy Prescription

Where

Convene (14th Street, DC)
600 14th St NW
Washington, DC 20005

When

{{getUserDateTimezone("1727350200").singleDate}}
{{getUserDateTimezone("1727350200").time}} - {{getUserDateTimezone("1727361000").time}} {{getClientTimezoneName()}}

About

Join STAT for a deep dive into how policy decisions are being made and what impact they’ll have on the health care system. With the election nearing, STAT reporters will sit down with lawmakers and other leaders to examine what we can expect from the future of health care policy.

Doors will open at 7:30 am ET. Programming is expected to run from 8:30 am to 10:00 am (exact timeline to be released with the agenda). Attendees are invited to stay after the program and network until as late as 12:00 pm ET.

Register

STAT+ Subscribers get free access – check your email for your exclusive promo code or reach out to our team at [email protected].


Agenda

7:30 – 8:45 a.m. ET – Arrival + Registration

Breakfast will be served

8:45 – 8:50 a.m.  ET – Opening from STAT

  • Rick Berke, co-founder and executive editor, STAT

8:50  – 8:55 a.m. ET – Welcome Remarks | Sponsor Session

  • Del Lebel, head, U.S. corporate affairs, Alexion, AstraZeneca Rare Disease

8:55 – 9:20 a.m. ET – Preparing for the Next Pandemic

The Administration for Strategic Preparedness and Response is tasked with handling a key part of pandemic response: the government’s stockpiles. Now, as H5N1’s spread in dairy cattle is making headlines, the agency is navigating budget talks, real-time demands, and still asking: how do we prepare for the next pandemic?

  • Dawn O’Connell, J.D., assistant secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services
  • Sarah Owermohle, Washington correspondent, STAT (moderator)

9:20 – 9:30 a.m. ET – Advancing Rare Disease Policy: A 2025 Agenda for Change | Sponsor Session

Thirty million Americans are living with a rare disease. What federal and state policies are needed to accelerate the research and development of new treatments?

  • Scott Weintraub, senior vice president, U.S. business, Alexion, AstraZeneca Rare Disease
  • Rick Berke, co-founder and executive editor, STAT (moderator)

9:30 – 9:50 a.m. ET – A Top Democratic Senator Looks Ahead on Health Care

Lawmakers are facing expiring deadlines in December for big-ticket health care policies. What can get done this year? Hear from a key member of the Senate’s health committee about payment reform for hospitals, regulating pharmacy benefit managers, expanding maternal health care, combatting the opioid crisis, and more.

  • Sen. Maggie Hassan (D-N.H.)
  • Rachel Cohrs Zhang, chief Washington correspondent, STAT (moderator)

9:50 – 10:05 a.m. ET – What Comes Next: The 2024 Election

How will the election impact health care? STAT’s Washington correspondents will discuss the future of Medicare, drug pricing, reproductive health, and what it all means for patients, providers, and the industry.

  • Sarah Owermohle, Washington correspondent, STAT 
  • Rachel Cohrs Zhang, chief Washington correspondent, STAT
  • John Wilkerson, Washington correspondent, STAT 
  • Rick Berke, co-founder and executive editor, STAT (moderator)

10:05 a.m. – 10:10 a.m.  ET – Closing from STAT

  • Matthew Herper, senior writer, medicine; editorial director of events, STAT

10:10 a.m. – 11:00 a.m. ET – Networking

Venue will be open for additional networking time

  • Alexion